{
    "2018-08-23": [
        [
            {
                "time": "2023-10-01",
                "original_text": "龙头股仍受青睐，多只个股回调获加仓",
                "features": {
                    "keywords": [
                        "龙头股",
                        "回调",
                        "加仓"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "[增持评级]长春高新(000661)中报点评：生长激素超预期增长 多重因素促进疫苗高速增长",
                "features": {
                    "keywords": [
                        "长春高新",
                        "生长激素",
                        "疫苗",
                        "超预期增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "[强烈推荐-A评级]长春高新(000661)中报点评：生物制剂增长超预期 生长激素龙头地位稳固",
                "features": {
                    "keywords": [
                        "长春高新",
                        "生物制剂",
                        "生长激素",
                        "龙头地位"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "[增持评级]长春高新(000661)半年报点评：业绩超预期 环比增速持续提升",
                "features": {
                    "keywords": [
                        "长春高新",
                        "业绩",
                        "环比增速",
                        "超预期"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "[买入评级]长春高新(000661)半年报点评：业绩持续高增长 生长激素龙头地位进一步巩固",
                "features": {
                    "keywords": [
                        "长春高新",
                        "业绩",
                        "高增长",
                        "生长激素",
                        "龙头地位"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "长春高新:生物药表现靓丽，业绩持续高增长",
                "features": {
                    "keywords": [
                        "长春高新",
                        "生物药",
                        "业绩",
                        "高增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "长春高新:生长激素与疫苗业绩大超预期",
                "features": {
                    "keywords": [
                        "长春高新",
                        "生长激素",
                        "疫苗",
                        "业绩",
                        "超预期"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}